Warning: The NCBI web site requires JavaScript to function. more...
Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer.
Sun Y, Turbin DA, Ling K, Thapa N, Leung S, Huntsman DG, Anderson RA.
Breast Cancer Res. 2010;12(1):R6. Epub 2010 Jan 14.
Related citations
Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
Wang XX, Zhu Z, Su D, Lei T, Wu X, Fan Y, Li X, Zhao J, Fu L, Dong JT, Fu L.
Hum Pathol. 2011 Oct;42(10):1410-9. Epub 2011 Mar 21.
P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC.
Clin Cancer Res. 2005 Aug 15;11(16):5869-77.
Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.
Hendrix A, Maynard D, Pauwels P, Braems G, Denys H, Van den Broecke R, Lambert J, Van Belle S, Cocquyt V, Gespach C, Bracke M, Seabra MC, Gahl WA, De Wever O, Westbroek W.
J Natl Cancer Inst. 2010 Jun 16;102(12):866-80. Epub 2010 May 18.
Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
Clin Cancer Res. 2005 Jun 15;11(12):4357-64.
Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T, Tsuda H, Moriya T, Yamasaki T, Kikuchi R, Ueda S, Omata J, Yamamoto J, Matsubara O.
Breast Cancer Res Treat. 2010 Oct;123(3):733-45. Epub 2009 Dec 18.
Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
Shida D, Fang X, Kordula T, Takabe K, Lépine S, Alvarez SE, Milstien S, Spiegel S.
Cancer Res. 2008 Aug 15;68(16):6569-77.
Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells.
Sarkar S, Maceyka M, Hait NC, Paugh SW, Sankala H, Milstien S, Spiegel S.
FEBS Lett. 2005 Oct 10;579(24):5313-7.
The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis.
Qin L, Liu Z, Chen H, Xu J.
Cancer Res. 2009 May 1;69(9):3819-27. Epub 2009 Apr 21.
Type I gamma phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with mu 1B adaptin.
Ling K, Bairstow SF, Carbonara C, Turbin DA, Huntsman DG, Anderson RA.
J Cell Biol. 2007 Jan 29;176(3):343-53.
Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
Clin Cancer Res. 2003 Nov 1;9(14):5313-7.
RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY, Wang WJ, Li QQ, Chen Q, Xu ZD, Liu XP.
Breast Cancer Res Treat. 2010 Sep;123(2):375-86. Epub 2009 Nov 28.
Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
Anticancer Res. 2005 May-Jun;25(3A):1615-22.
Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H, Cai Y, Wainberg ZA, Garraway I, Lascombe I, Nicolle G, Thiery JP, Bittard H, Radvanyi F, Reiter RR.
Urol Oncol. 2010 Mar-Apr;28(2):180-8. Epub 2008 Dec 12.
Biological and clinical implications of nicastrin expression in invasive breast cancer.
Filipović A, Gronau JH, Green AR, Wang J, Vallath S, Shao D, Rasul S, Ellis IO, Yagüe E, Sturge J, Coombes RC.
Breast Cancer Res Treat. 2011 Jan;125(1):43-53. Epub 2010 Mar 12.
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H, Stephens LC, Kumar R.
Clin Cancer Res. 2006 Mar 1;12(5):1479-86.
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
Habashy HO, Powe DG, Staka CM, Rakha EA, Ball G, Green AR, Aleskandarany M, Paish EC, Douglas Macmillan R, Nicholson RI, Ellis IO, Gee JM.
Breast Cancer Res Treat. 2010 Jan;119(2):283-93. Epub 2009 Feb 24.
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Yau C, Benz CC.
Breast Cancer Res. 2008;10(4):R61. Epub 2008 Jul 17.
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R, Kelsch R, Fischgräbe J, Smollich M, Rossi LH, Sibrowski W, Wülfing P, Kiesel L, Yip GW, Götte M.
Carcinogenesis. 2009 Mar;30(3):397-407. Epub 2009 Jan 6.
Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
Nakamura Y, Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Nakao K, Nakamura M, Kakudo K.
Clin Cancer Res. 2006 Feb 15;12(4):1201-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on